]>
IRCT20130812014333N154 IRCT 2020-11-06 Kermanshah University of Medical Sciences The effect of Percutaneous embolization in patients with symptomatic liver hemangiomas Study of the effect of Percutaneous embolization with bleomycin sclerosing in patients with symptomatic liver hemangiomas 2020-11-10 anticipated 19 Complete https://irct.ir/trial/51694 interventional Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Using the random number table, patients are divided into two groups of 19. Each patient is assigned a 4-digit code based on the random number table, Based on the right number of patients code, the patients are divided into two groups. Patients whose last digit is 0, 2, 4, 6, 8 will be assigned to the intervention group and patients whose last digit is 1,3,5, 7, 9 will be assigned to the control group. 2-3 Liver symptomatic hemangioma. Intervention 1: In the intervention group, sclerotherapy (with 18 or 20 gage needles) will be performed with a mixture of 20 cc of IU 45 Bleomycin in 10 cc of distilled water and 10 cc of lipividol. Intervention 2: No intervention will be performed in the control group. Yes - There is a plan to make this available What will be shared: The main outcomes of the study will be shared. When: 3 months To whom: If requested, results will be made available to other academic researchers Conditions: Collected data is confidential and will not be shared with anyone else Where to obtain: Send E-mail to the responsible for the update to get the documentation How to obtain: Documentation will be emailed within a 15-day timeframe Comments:
public Dr. Loura Khanian
Emam Reza Hospital, Parastar Boulevard
Kermanshah Iran (Islamic Republic of) 6715847141 +98 83 3427 6306 Loura.Khanian@yahoo.com Kermanshah University of Medical Sciences scientific Dr. Mohammad Gharib SAlehi
Emam Reza Hospital, Parastar Boulevard
Kermanshah Iran (Islamic Republic of) 6715847141 +98 83 3427 6306 Kumssalehi@yahoo.com Kermanshah University of Medical Sciences Iran (Islamic Republic of) A giant hepatic hemangioma with clear margins The number of platelets is more than 100,000 International Ratio Normalized less than 1/5 no limit no limit Both Patients with severe ascites Improper position of the hemangioma Patients with hepatic or renal impairment D18.0 Haemangioma, any site Treatment - Other N/A In the intervention group, sclerotherapy (with 18 or 20 gage needles) will be performed with a mixture of 20 cc of IU 45 Bleomycin in 10 cc of distilled water and 10 cc of lipividol No intervention will be performed in the control group. Ultrasound volume. Timepoint: At the beginning of the study and 6 months after the end of the study. Method of measurement: Using the GE-Logic S6 ultrasound device. Largest diameter of ultrasond. Timepoint: At the beginning of the study and 6 months after the end of the study. Method of measurement: Using the GE-Logic S6 ultrasound device. Kermanshah University of Medical Sciences Approved 2020-03-02 Ethics committee of Kermanshah University of Medical Sciences Building No.2, Shahid Beheshti, Vice Chancellor for Research Affairs, Kermanshah University of Medical Sciences Kermanshah Kermanshah Iran (Islamic Republic of)